Search for: "Pharmaceutical Associates, Inc."
Results 601 - 620
of 1,891
Sorted by Relevance
|
Sort by Date
23 Jul 2007, 6:58 am
Costello is an associate resident in the Atlanta office of Jones Day. [read post]
25 Apr 2010, 5:52 pm
II) – This case stems from a February 2009 challenge by the FTC and the California Attorney General concerning Solvay Pharmaceuticals, Inc. [read post]
29 May 2024, 11:27 am
Regeneron Pharmaceuticals, Inc. v. [read post]
1 Jun 2012, 2:30 am
Stokes’ lawsuit names the McKesson Corporation, Wyeth Pharmaceuticals Inc., Pfizer Inc. and Schwarz Pharma Inc. as defendants in her lawsuit. [read post]
6 Mar 2008, 5:55 am
"As the number of documents to be reviewed explodes, this partnership will decrease the costs associated with complex litigation," notes Mike Dolan, CEO of Tusker Group. [read post]
5 Jan 2008, 6:00 am
You can separately subscribe to the IP Think Tank Global week in Review at [feeds.feedburner.com]GlobalComing out of copyright - some notable deaths from 1937: (IPKat),Design patents: No longer the province of individual inventors: (Patently O),Fail fast, ready fire aim and Stanford v Cal: (IP Think Tank),Walls, Alexander the Great and Partha Bose: (IP Think Tank),A fair use primer for online content creators: (Ars Technica)ISO moves to create global… [read post]
1 Apr 2010, 3:04 am
– TRIPS and price controls on patented pharmaceutical products (patentidbits) Assessing pharma patent strength (JIPLP) Canada: Health Canada releases final guidances on biosimilars (Pharmacapsules) US: District Court S D New York: ‘Isolated DNA’ patents fail to claim patentable subject matter: Association for Molecular Pathology and ACLU v. [read post]
28 Jun 2010, 5:13 pm
©2010 Amaxx Risk Solutions, Inc. [read post]
29 Oct 2020, 10:56 am
In Regeneron Pharmaceuticals Inc v. [read post]
12 Dec 2021, 2:22 pm
Whitehall Labs., Inc., 874 F. [read post]
13 May 2021, 1:32 pm
Anixa Biosciences, Inc. [read post]
16 Oct 2008, 8:19 pm
We had previously written a blog about Byetta developed by Eli Lilly and Company and Amylin Pharmaceuticals, Inc. [read post]
18 Feb 2010, 12:36 am
Court of Appeals for the 1st Circuit challenging different aspects of a Boston federal court ruling against the Real Estate Bar Association for Massachusetts Inc. [read post]
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid: (IPLaw360), … [read post]
27 Apr 2010, 10:58 pm
(The SPC Blog) EU: Originator drug companies hit by European ruling: C-62/09 Association of the British Pharmaceutical Industry (Managing Intellectual Property) EU: EPO – Convention on Biological Diversity and the exception to patentability for inventions which are contrary to ‘ordre public’ or morality (EPLAW) India: Patent office releases details on pharmaceutical product patents granted in last 3 years (Generic Pharmaceuticals and IP) (Spicy… [read post]
10 Mar 2014, 11:31 am
In Centocor, Inc. v. [read post]
28 Apr 2011, 6:26 pm
©2011 Amaxx Risk Solutions, Inc. [read post]
6 Sep 2015, 8:26 am
" Purdue Pharma paid $600 million in fines, among the largest settlements in U.S. history for a pharmaceutical company.Three former and current executives of Purdue Pharma, LP, the maker of OxyContin, pled guilty to misdemeanor charges of drug misbranding on May 10, acknowledging that they deceived consumers about the risks associated with the drug. [read post]
5 Jun 2013, 9:34 am
The laws that apply to generic drugs recently shifted in favor of the manufacturers at the expense of injured consumers in 2011 when the United States Supreme Court ruled in the case of Pilva, Inc. v. [read post]
13 Dec 2013, 11:04 am
Circuit, in Sottera, Inc. v. [read post]
